May 20,2019

Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Medicine Platform

Biofourmis, a fast-growing leader in digital medicine, today announced that it has successfully closed $35 million in Series B financing. The new injection of funding and move to the U.S. will enable Biofourmis to advance its proprietary artificial intelligence (AI)-powered digital medicine platform and pipeline that treats and manages a range of complex chronic conditions.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 29,2014

Boston Business Journal: GNS Healthcare raises $10M for big data

GNS Healthcare Inc. has raised a $10 million Series B funding round led by existing investor Cambia Health Solutions, based in Portland Oregon. New investors, California�s Heritage Provider Network and Mitsui & Co also joined the round. The announcement follows the Cambridge company�s expansion to a second office in Austin, Texas, and a plan to grow head count to 80 from 50 by year�s end, CEO Colin Hill said. Cambridge-based GNS Healthcare provides data analytics to biotechnology companies including Biogen Idec and Genzyme Corp., health insurers like Aetna and research hospital powerhouses like Dana-Farber Cancer Institute and Brigham and Women�s Hospital. Proceeds of the financing will be used to expand GNS Healthcare�s business across the health care industry.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 07,2014

Flatiron Health Raises $130 Million Series B Round Led by Google Ventures and Agrees to Acquire Leading Cloud-Based EMR Company Altos Solutions

Flatiron Health, developers of the OncoCloud� platform, today announced a $130 million raise for its Series B venture capital round. The financing round is being led by Google Ventures, with participation from existing investors First Round Capital and Laboratory Corporation of America Holdings (LabCorp�). As a part of the financing, Andrew Conrad, Director at Google[X], will join Flatiron Health�s board of directors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 10,2014

Syapse Raises $10 Million Series B Financing Led by Safeguard Scientifics

Syapse, creators of the Precision Medicine Data Platform, today announced that it raised $10 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor, The Social+Capital Partnership. This financing will enable Syapse to extend its lead in helping healthcare providers deploy precision medicine programs to utilize genomics and clinical data to support treatment decisions. In addition, Syapse will use proceeds to expand sales, marketing and client services, as well as further accelerate product development. To date, Syapse has raised a total of $14.5 million.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 16,2016

Oncology-centric informatics firm Cota raises $18M

Cota, an oncology-centric data analytics company, has closed an $18 million growth equity round. Boston Millennia Partners was among the new investors in Cota, which builds technology to measure patient outcomes from specific treatment protocols. (The name stands for Cancer Outcomes Tracking and Analysis.) This is the second major investment in Cota this year. In May, pharma manufacturers Celgene and Novartis joined molecular information company Foundation Medicine and consulting firm HealthScape Advisors to make unspecified investments.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Mar 01,2017

Medisafe raises $14.5M, announces European expansion

Medication adherence startup MediSafe has raised $14.5 million in a round led by Octopus Ventures and M Ventures (the venture arm of Merck Pharmaceuticals), with participation from existing investors Pitango Venture Capital, 7wire ventures, lool Ventures, TriVentures and Qualcomm Ventures. The company also announced that it will begin expanding into Europe using some of the funds.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 30,2018

SkinVision gets $7.6M to continue expanding skin cancer app

Amsterdam-based skin cancer screening app SkinVision has raised $7.6 million in new funding from existing investors Leo Pharma and PHS Fund, with additional contributions from undisclosed new backers described by the company as "high net worth impact investors." This is the second major funding raise for the company, which launched in 2012 under the name Skin Scan, after a $3.4 million round in 2015. It also received some additional funding from Leo in 2017. The company's total funding stands at $13 million.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 05,2018

Oncology Analytics Raises $21M Series B

Atlanta-based Oncology Analytics has closed on a $21 million Series B funding round led by Oak HC/FT. New investor McKesson Ventures, along with returning investors Blue Cross Blue Shield Venture Partners and Sandbox Advantage Fund, also participated in the �oversubscribed� financing. Combined with a $7.5 million Series A raise in March 2016, the company has raised a total of $28.5 million.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 17,2019

PathAI Secures $60M in Series B Funding

PathAI, a Boston, MA-based global provider of artificial intelligence-powered technology for pathology, raised $60m in Series B funding. The round was led by new investor General Atlantic, with participation from General Catalyst and other existing investors. In conjunction with the funding, General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI�s board of directors.The company intends to use the funds to: � enhance offerings to existing partners, � drive continuous improvement of its flagship pathology research platform, � meet market demands, and � accelerate research and development into new tools and medical devices.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 08,2019

LetsGetChecked raises $30 million for at-home medical tests

The fresh cash brings LetsGetChecked�s total raised to roughly $48.9 million, following a $14.5 million series A raise in July 2016. CEO and founder Peter Foley said the company will use the funds to scale its diagnostics products in the U.S. and internationally, further develop its technology platform, and expand its U.S. manufacturing and logistics operations.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES B